Literature DB >> 23759424

Acid suppression and the risk of Clostridium difficile infection.

Ethan A Mezoff1, Mitchell B Cohen.   

Abstract

Entities:  

Keywords:  CA-CDI; CDAD; CDI; Clostridium difficile infection; Clostridium difficile-associated disease; Community acquired CDI; H2RA; Histamine type 2 receptor antagonist; PPI; Proton pump inhibitor

Mesh：

Substances：

Year:  2013        PMID： 23759424      PMCID： PMC3755114          DOI： 10.1016/j.jpeds.2013.04.047

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  53 in total

1.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Authors:  Michael D Howell; Victor Novack; Philip Grgurich; Diane Soulliard; Lena Novack; Michael Pencina; Daniel Talmor
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

Authors:  John M Inadomi; Lisa McIntyre; Latoya Bernard; A Mark Fendrick
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

3.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

Review 4.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Clostridium difficile infection in hospitalized children in the United States.

Authors:  Cade M Nylund; Anthony Goudie; Jose M Garza; Gerry Fairbrother; Mitchell B Cohen
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01-03

6.  A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.

Authors:  Susanna Naggie; Becky A Miller; Kimberly B Zuzak; Brian W Pence; Ashley J Mayo; Bradly P Nicholson; Preeta K Kutty; L Clifford McDonald; Christopher W Woods
Journal:  Am J Med       Date:  2011-03       Impact factor: 4.965

7.  Possible foodborne transmission in a case of pseudomembranous colitis due to Clostridium difficile: influence of gastrointestinal secretions on Clostridium difficile infection.

Authors:  L Gurian; T T Ward; R M Katon
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?

Authors:  Robin L P Jump; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

10.  Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA.

Authors:  Preeta K Kutty; Christopher W Woods; Arlene C Sena; Stephen R Benoit; Susanna Naggie; Joyce Frederick; Sharon Evans; Jeffery Engel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883
View more
  6 in total

1.  Effect of Metronidazole in Infants with Bowel Habit Change: Irrelative to the Clostridium difficile Colonization.

Authors:  Eun Jin Kim; Sung Hyun Lee; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-03-27

2.  Risk factors associated with Clostridium difficile infection in adult oncology patients.

Authors:  Analia Rodríguez Garzotto; Antonio Mérida García; Nerea Muñoz Unceta; M Mar Galera Lopez; M Ángeles Orellana-Miguel; C Vanesa Díaz-García; Susana Cortijo-Cascajares; Hernán Cortes-Funes; M Teresa Agulló-Ortuño
Journal:  Support Care Cancer       Date:  2014-11-20       Impact factor: 3.603

3.  Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-04       Impact factor: 2.839

4.  Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

Review 5.  Clostridium difficile colitis and zoonotic origins-a narrative review.

Authors:  Alexander W W Brown; Robert B Wilson
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-06-28

6.  When omeprazole met with asymptomatic Clostridium difficile colonization in a postoperative colon cancer patient: A case report.

Authors:  Boyu Li; Huachong Ma; Zhenjun Wang; Lihong Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.